Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04188613
Other study ID # HFJV
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 1, 2019
Est. completion date April 1, 2020

Study information

Verified date January 2021
Source Diskapi Yildirim Beyazit Education and Research Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Percutaneous tracheostomy is the mouth opening of the tracheal ostium to the skin by creating an opening in the anterior wall of the trachea using Seldinger methods. This procedure is done using an endotracheal tube (ETT) or a laryngeal mask (LMA). High-frequency jet ventilation (HFJV) commonly used in oropharyngeal surgeries and creates an extra passage for the procedure. The investigators aimed to demonstrate the effective use of HFJV in percutaneous tracheostomy.


Description:

Seventy five patients between 18-80 years of age who were hospitalized in intensive care unit were included in the study. The number of patients will be finalized by power analysis. whose written consent cannot be obtained and who undergo surgical tracheostomy for any reason will be excluded from the study. In addition, patients with active infection in the area of the procedure, bleeding diathesis and pathologies that interfere with the procedure in the ultrasonographic evaluation (thyroid diseases, etc.) will be excluded from the study. Patients will be divided into three groups as those using classical ventilation (group 1), HFJV (group 2) and classical laryngeal mask (group 3). Age, gender, height, BMI, ASA scores, presence and type of additional diseases, tracheostomy day, pre- and post-procedure blood gas analysis, duration of procedure, duration of anesthesia, complications during the procedure (bleeding , desaturation, accidental extubation, malposition, bradycardia, hypotension, etc.) will be recorded. Patients will be observed for mortality in the first 30 days after the procedure. Mortality results will be recorded.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date April 1, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - percutaneous tracheostomy procedure Exclusion Criteria: - whose written consent cannot be obtained - who undergo surgical tracheostomy for any reason - patients with active infection in the area of the procedure, - bleeding diathesis - pathologies that interfere with the procedure in the ultrasonographic evaluation (thyroid diseases, etc.)

Study Design


Intervention

Device:
Percutaneous tracheostomy
Age, gender, height, BMI, ASA scores, presence and type of additional diseases, tracheostomy day, pre- and post-procedure blood gas analysis, duration of procedure, duration of anesthesia, complications during the procedure (bleeding , desaturation, accidental extubation, malposition, bradycardia, hypotension, etc.) will be recorded from intensive care follow-up. Patients will be observed for mortality in the first 30 days after the procedure. Mortality results will be recorded.

Locations

Country Name City State
Turkey Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital Ankara, Turkey Ankara

Sponsors (1)

Lead Sponsor Collaborator
Diskapi Yildirim Beyazit Education and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary percutaneous tracheostomy time the time the needle enters the skin to the insertion of the tracheostomy cannula during procedure
Secondary complications rate the complications such as ET cuff puncture, Difficult insertion of tracheostomy tube, Accidental extubation, Bleeding vs. during percutaneous tracheostomy during procedure
See also
  Status Clinical Trial Phase
Completed NCT05084976 - Parental Perception of COVID-19 Vaccine in Technology Dependent Patients
Active, not recruiting NCT04308109 - Simulation Training in the Pediatric Tracheostomy and Home Ventilator Population N/A
Recruiting NCT02495558 - Cough Assessment in Patients With Severe Acquired Brain Injury N/A
Completed NCT04637932 - Percutaneous Dilatation Tracheostomy, Broncoscopy, Pro-seal Laryngeal Mask N/A
Completed NCT05499273 - Pediatric Neck Rescue Access Comparison N/A
Recruiting NCT04565405 - Microbiological Evaluation of the Efficacy of Water to Clean Tracheostomy Inner Cannulas N/A
Recruiting NCT05395728 - Deflating the Tracheostomy Tube Cuff and Time for Decannulation N/A
Withdrawn NCT02074254 - Safety of Percutaneous Tracheostomy in Clopidogrel and Selective Serotonin Reuptake Inhibitors
Not yet recruiting NCT02096640 - Postoperative Inflammation and Recovery After Tracheostomy N/A
Completed NCT05045885 - Safety and Feasibility of Percutaneous Dilatational Tracheostomy in Patients With Severe COVID-19 Supported by ECMO
Completed NCT04744909 - Navigation System for Percutaneous Tracheotomy N/A
Completed NCT04412356 - Timing of Tracheotomy in Covid-19 Patients N/A
Recruiting NCT06018220 - Percutaneous Dilatational Tracheostomy vs. Surgical Tracheostomy in Neurocritically Ill Patients - a Retrospective Study
Not yet recruiting NCT05834972 - Ultrasound-guided Versus Landmark-guided Percutaneous Dilational Tracheostomy in Pediatric Patients
Withdrawn NCT04685902 - Assessing Upper Airway Patency in Tracheostomy Patients During One Way Speaking Valve Trial
Not yet recruiting NCT05418517 - Hospital Acquired Pneumonia in Temporary Tracheostomy
Completed NCT04987398 - Ventilation Weaning Strategies and Correlation to Outcomes in Tracheostomized Patients in the Lausanne ICU
Completed NCT03431389 - "Outcomes of Tracheostomy Done for Patients Admitted in Anesthesia Intensive Care Units of Assiut University Hospital" Phase 2/Phase 3
Withdrawn NCT03325725 - Intra-laryngeal Implant for Treatment of Chronic Aspirations N/A
Completed NCT05595707 - Expert-Guided Early Tracheostomy Pathway N/A